Loading clinical trials...
Loading clinical trials...
A PHASE 1, OPEN-LABEL STUDY TO EVALUATE THE PHARMACOKINETIC INTERACTIONS BETWEEN PF-06882961 AND PF-06865571 IN HEALTHY ADULT PARTICIPANTS (PART A) AND OVERWEIGHT ADULTS OR ADULTS WITH OBESITY WHO ARE OTHERWISE HEALTHY (PART B)
Conditions
Interventions
PF-06882961 followed by PF-06882961/PF-06865571
PF-06882961/PF-06865571 followed by PF-06882961
+1 more
Locations
1
United States
Orange County Research Center
Tustin, California, United States
Start Date
April 5, 2021
Primary Completion Date
October 10, 2021
Completion Date
November 8, 2021
Last Updated
August 21, 2023
NCT00104325
NCT07118891
NCT03878121
NCT01399385
NCT07295717
NCT03807401
Lead Sponsor
Pfizer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions